178 related articles for article (PubMed ID: 37016317)
1. Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation.
Jiao J; Ruan L; Cheng CS; Wang F; Yang P; Chen Z
Mol Med; 2023 Apr; 29(1):47. PubMed ID: 37016317
[TBL] [Abstract][Full Text] [Related]
2. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
[TBL] [Abstract][Full Text] [Related]
3. RIPK2 promotes the progression of colon cancer by regulating BIRC3-mediated ubiquitination of IKBKG.
Zhang Z; Pan Y; Zhao Y; Ren M; Li Y; Lu G; He S
Exp Cell Res; 2023 Aug; 429(1):113644. PubMed ID: 37211186
[TBL] [Abstract][Full Text] [Related]
4. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.
Zhang W; Wang Y
Histochem Cell Biol; 2022 Feb; 157(2):173-182. PubMed ID: 34825931
[TBL] [Abstract][Full Text] [Related]
5. High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer.
Shen Y; Lin H; Chen K; Ge W; Xia D; Wu Y; Lu W
J Ovarian Res; 2022 Apr; 15(1):48. PubMed ID: 35477477
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells.
Wu S; Kanda T; Nakamoto S; Imazeki F; Yokosuka O
Anticancer Res; 2012 Sep; 32(9):3775-83. PubMed ID: 22993319
[TBL] [Abstract][Full Text] [Related]
7. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
8. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA.
Li X; Li Z; Zhu H; Yu X
Biomed Res Int; 2020; 2020():8537381. PubMed ID: 33204717
[TBL] [Abstract][Full Text] [Related]
9. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours.
Zhang H; Ma Y; Zhang Q; Liu R; Luo H; Wang X
BMC Med Genomics; 2022 Apr; 15(1):97. PubMed ID: 35473583
[TBL] [Abstract][Full Text] [Related]
10. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.
Chen PS; Shih YW; Huang HC; Cheng HW
PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
12. Cell death gene expression profile: role of RIPK2 in dengue virus-mediated apoptosis.
Morchang A; Yasamut U; Netsawang J; Noisakran S; Wongwiwat W; Songprakhon P; Srisawat C; Puttikhunt C; Kasinrerk W; Malasit P; Yenchitsomanus PT; Limjindaporn T
Virus Res; 2011 Mar; 156(1-2):25-34. PubMed ID: 21195733
[TBL] [Abstract][Full Text] [Related]
13. Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer.
Jaafar RF; Ibrahim Z; Ataya K; Hassanieh J; Ard N; Faraj W
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356990
[No Abstract] [Full Text] [Related]
14. p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway.
Tyagi N; Bhardwaj A; Singh AP; McClellan S; Carter JE; Singh S
Oncotarget; 2014 Sep; 5(18):8778-89. PubMed ID: 25238288
[TBL] [Abstract][Full Text] [Related]
15. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
[TBL] [Abstract][Full Text] [Related]
16. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.
Li B; Pang S; Dou J; Zhou C; Shen B; Zhou Y
Clin Transl Oncol; 2022 Jun; 24(6):1059-1072. PubMed ID: 35066757
[TBL] [Abstract][Full Text] [Related]
18. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.
Nomoto D; Baba Y; Liu Y; Tsutsuki H; Okadome K; Harada K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Moroishi T; Komohara Y; Sawa T; Baba H
Cancer Lett; 2022 Apr; 530():59-67. PubMed ID: 35033591
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-κB pathway dependent repression of PP2Ac.
Tao M; Liu L; Shen M; Zhi Q; Gong FR; Zhou BP; Wu Y; Liu H; Chen K; Shen B; Wu MY; Shou LM; Li W
Cell Cycle; 2016; 15(3):381-93. PubMed ID: 26761431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
